Why the study?
Does endothelial dysfunction, measured by reactive hyperaemia, predict adverse outcomes in patients with congestive heart failure?
Does endothelial dysfunction, measured by reactive hyperaemia, predict adverse outcomes in patients with congestive heart failure?
Endothelial dysfunction, measured by post-hyperaemia forearm blood flow, is an independent predictor of major adverse events in patients with congestive heart failure.
Answers are grounded in this paper and cite their sources.
Endothelial dysfunction assessment may refine HF prognostication; hypothesis-generating and requires prospective validation before clinical adoption.
AIMS: In congestive heart failure (CHF), arterial response is regulated by endothelial molecules. The aim of this study was to evaluate whether endothelial dysfunction (ED) was a predictor of outcome in a cohort of patients with heart failure. METHODS AND RESULTS: Endothelial function was assessed in 242 patients with CHF by forearm reactive hyperaemia measured with intermittent venous occlusion plethysmography using a mercury strain gauge. The main endpoints were: 'total events' (death, heart attack, angina, stroke, NYHA class IV, or hospitalization due to heart failure) analysed using Cox regression for repeated events and 'death'. Patients were followed-up for 5 years. Post-hyperaemia forearm blood flow (PHFABF) was an independent predictor of total events [P = 0.01; hazard ratio [Exp(B)] 0.665, standard error (SE) 0.182]. Risk stratification by basal forearm blood flow (BFABF) showed that patients with basal blood flow above the median (3.03 mL min(-1) 100 mL(-1)) benefited from an increase in PHFABF, whereas in patients with a BFABF below the median, the increase in PHFABF did not diminish the risk of events. There was no relation between variations in PHFABF and death. CONCLUSION: Post-hyperaemia forearm blood flow, as a measure of ED, is an independent predictor of major events in patients with CHF. A BFABF below the median is more predictive of an increased risk of complications.
No takes yet. Share an insight, caveat, or question.
Berrazueta et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: